Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hoyo-Vadillo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Life Sciences|January 1, 1995
Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivoC Hoyo-Vadillo, J W Mandema, M Danhof
Arzneimittel-Forschung|May 1, 1995
Relationship between naproxen plasma concentration and its anti-inflammatory effect in experimental hepatitisG Castañeda-Hernández, L Favari, C Hoyo-Vadillo
Arzneimittel-Forschung|June 1, 1993
Pharmacokinetics and pharmacodynamics of naproxen in acute experimental hepatitisL Favari, G Castañeda-Hernández, C Hoyo-Vadillo
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1995
Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administrationG Castañeda-Hernández, C Hoyo-Vadillo, J E Herrera
The Journal of Pharmacy and Pharmacology|June 1, 1995
Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesics to their efficacy in ratsC Hoyo-Vadillo, J Pérez-Urizar, F J López-Munoz
Journal of Clinical Pharmacology|February 1, 1993
Pharmacokinetics of oral nifedipine in different populationsG Castañeda-Hernández, C Hoyo-Vadillo, J A Palma-Aguirre, et al.
Journal of Clinical Pharmacy and Therapeutics|May 27, 2018
CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamideO D Castelán-Martínez, C Hoyo-Vadillo, T B Bazán-Soto, et al.
Journal of Clinical Pharmacology|September 1, 1989
Pharmacokinetics of nifedipine slow release tablet in Mexican subjects: further evidence for an oxidation polymorphismC Hoyo-Vadillo, G Castañeda-Hernández, J E Herrera, et al.
American Journal of Therapeutics|January 1, 1995
Discrepancy between Bioavailability and Hypotensive Effect of Oral and Sublingual NifedipineJ. A. Palma-Aguirre, M. A. Montoya-Cabrera, P. du Souich, et al.
Journal of Clinical Pharmacology|March 1, 1989
Pharmacokinetics of oral nifedipine: relevance of the distribution phaseC Hoyo-Vadillo, G Castañeda-Hernández, J E Herrera, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Life Sciences|January 1, 1995
Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivoC Hoyo-Vadillo, J W Mandema, M Danhof
Arzneimittel-Forschung|May 1, 1995
Relationship between naproxen plasma concentration and its anti-inflammatory effect in experimental hepatitisG Castañeda-Hernández, L Favari, C Hoyo-Vadillo
Arzneimittel-Forschung|June 1, 1993
Pharmacokinetics and pharmacodynamics of naproxen in acute experimental hepatitisL Favari, G Castañeda-Hernández, C Hoyo-Vadillo
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1995
Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administrationG Castañeda-Hernández, C Hoyo-Vadillo, J E Herrera
The Journal of Pharmacy and Pharmacology|June 1, 1995
Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesics to their efficacy in ratsC Hoyo-Vadillo, J Pérez-Urizar, F J López-Munoz
Journal of Clinical Pharmacology|February 1, 1993
Pharmacokinetics of oral nifedipine in different populationsG Castañeda-Hernández, C Hoyo-Vadillo, J A Palma-Aguirre, et al.
Journal of Clinical Pharmacy and Therapeutics|May 27, 2018
CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamideO D Castelán-Martínez, C Hoyo-Vadillo, T B Bazán-Soto, et al.
Journal of Clinical Pharmacology|September 1, 1989
Pharmacokinetics of nifedipine slow release tablet in Mexican subjects: further evidence for an oxidation polymorphismC Hoyo-Vadillo, G Castañeda-Hernández, J E Herrera, et al.
American Journal of Therapeutics|January 1, 1995
Discrepancy between Bioavailability and Hypotensive Effect of Oral and Sublingual NifedipineJ. A. Palma-Aguirre, M. A. Montoya-Cabrera, P. du Souich, et al.
Journal of Clinical Pharmacology|March 1, 1989
Pharmacokinetics of oral nifedipine: relevance of the distribution phaseC Hoyo-Vadillo, G Castañeda-Hernández, J E Herrera, et al.
Pageof 2